Manufacturing News of Note—Taro recalls seizure drugs; explosions at API plant  

A closeup of a stock market ticker
(Pixabay)

> Taro Pharmaceuticals is voluntarily recalling two lots of phenytoin oral suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level because they may not re-suspend when shaken, potentially leading to dosing issues. Release 

> The Massachusetts State Fire Marshal determined that several explosions Feb. 13 at a PCI Synthesis API plant in Newburyport occurred during a sampling procedure. No one was injured. Release  

> Catalent Pharma Solutions will offer nearly $500 million in senior unsecured notes due 2028. Release 

> Italy-based CDMO and API maker Dipharma has completed a new quality control laboratory and kilolab at its CDMO site in Kalamazoo, Michigan. Release

Suggested Articles

Mylan recalls one lot of the injectable antibiotic daptomycin after discovering particles in a single-dose vial.

Lupin Pharmaceuticals pulled all lots of its extended-release diabetes drug metformin amid carcinogen contamination concerns.

Novartis and Civica Rx are patterning up to shore up supply of six key generic injectables used in acute care settings in hospitals.